H-SLLTEVETPIRNEWGSRSNDSSD-OH
Ref. 3D-PP42815
1mg | 407,00 € | ||
10mg | 494,00 € | ||
100mg | 889,00 € |
Informação sobre produto
- NH2-Ser-Leu-Leu-Thr-Glu-Val-Glu-Thr-Pro-Ile-Arg-Asn-Glu-Trp-Gly-Ser-Arg-Ser-Asn-Asp-Ser-Ser-Asp-OH
Peptide H-SLLTEVETPIRNEWGSRSNDSSD-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SLLTEVETPIRNEWGSRSNDSSD-OH include the following: Towards improved and broadly protective influenza vaccines: Focus on delivery systems, routes of administration and animal models Y Bhide - 2018 - research.rug.nlhttps://research.rug.nl/en/publications/towards-improved-and-broadly-protective-influenza-vaccines-focus- pter 2 WD Yoshita Bhide, I Gribonika, D Voshart - Diseases , 2018 - research.rug.nlhttps://research.rug.nl/files/64971290/Complete_thesis.pdf#page=32 Porous nanoparticles with self-adjuvanting M2e-fusion protein and recombinant hemagglutinin provide strong and broadly protective immunity against influenza virus V Bernasconi, B Bernocchi, L Ye , MQ Le - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2018.02060/full Design of a Universal Influenza A Vaccine Candidate Based on M2e. FliC; Immunoinformatics Analysis, Protein Modeling, and Its Expression in Escherichia SMJ Kolour , F Behzadian, B Farahmand - Jundishapur Journal of , 2018 - brieflands.comhttps://brieflands.com/articles/jjm-66592 In contrast to conventional inactivated influenza vaccines, 4xM2e. HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A SM Ebrahimi, M Dabaghian, M Tebianian , MHZ Jazi - Virology, 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0042682212002103 Synthetic long peptide influenza vaccine containing conserved T and B cell epitopes reduces viral load in lungs of mice and ferrets SK Rosendahl Huber, MGM Camps, RHJ Jacobi - PloS one, 2015 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0127969 Antigen-presenting, self-assembled protein nanobarrels as an adjuvant-free vaccine platform against influenza virus S Kang, Y Kim , Y Shin, JJ Song, S Jon - ACS nano, 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsnano.1c04078 IMOJEV®: a Yellow fever virus-based novel Japanese encephalitis vaccine MB Appaiahgari , S Vrati - Expert review of vaccines, 2010 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1586/erv.10.139 Generation of Broad Protection against Influenza with Di-Tyrosine-Cross-Linked M2e Nanoclusters LR Wilks, G Joshi , N Rychener, HS Gill - ACS Infectious Diseases, 2024 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsinfecdis.3c00429 Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge L Deng, JR Kim, TZ Chang , H Zhang, T Mohan - Virology, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S004268221730171X A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus DG Eliasson, A Helgeby, K Schön, C Nygren - Vaccine, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X1100483X< Valentina Bernasconi1, Beatrice Bernocchi2, Liang Ye3, Minh Quan Lacaª2, Ajibola Omokanye1, Rodolphe Carpentier2, Karin Schön1, Xavier Saelens4, 5, Peter C Chevalier - Innovative Therapeutic and Vaccine Approaches , 2020 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=-YLhDwAAQBAJ&oi=fnd&pg=PA20&dq=(%22H-SLLTEVETPIRNEWGSRSNDSSD-OH%22+OR+%22SLLTEVETPIRNEWGSRSNDSSD%22+OR+%22NH2-Ser-Leu-Leu-Thr-Glu-Val-Glu-Thr-Pro-Ile-Arg-Asn-Glu-Trp-Gly-Ser-Arg-Ser-Asn-Asp-Ser-Ser-Asp-OH%22)+AND+peptide&ots=07ycxq48Vr&sig=m3b4Yg-JbFMxJQwAZzrIn35RORA Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes BR Park, J Subbiah , KH Kim , YM Kwon, J Oh, MC Kim - Virology, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0042682221002439 Nanoparticles Carrying Conserved Regions of Influenza A Hemagglutinin, Nucleoprotein, and M2 Protein Elicit a Strong Humoral and T Cell Immune Response and AA Zykova, EA Blokhina, LA Stepanova, MA Shuklina - Molecules, 2023 - mdpi.comhttps://www.mdpi.com/1420-3049/28/18/6441 Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirus AA Rumyantsev, Z Zhang, Q Gao, N Moretti, N Brown - Virology, 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0042682209006576
Propriedades químicas
Consulta técnica sobre: 3D-PP42815 H-SLLTEVETPIRNEWGSRSNDSSD-OH
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.